Anticonvulsants to treat post-traumatic stress disorder

Human Psychopharmacology

Volumn 29, Issue 5, 2014, Pages 427-433

  Wang, Hee Ryung ^a   Woo, Young Sup ^a   Bahk, Won Myong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Anticonvulsant; Efficacy; Post traumatic stress disorder; Safety

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; ANXIOLYTIC AGENT; FRUCTOSE; NIPECOTIC ACID DERIVATIVE; TRIAZINE DERIVATIVE; VALPROIC ACID;

ANTICONVULSANT THERAPY; CLINICAL EFFECTIVENESS; HUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANALOGS AND DERIVATIVES; STRESS DISORDERS, POST-TRAUMATIC;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; FRUCTOSE; HUMANS; NIPECOTIC ACIDS; STRESS DISORDERS, POST-TRAUMATIC; TRIAZINES; VALPROIC ACID;

EID: 84922691684     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2425     Document Type: Review

References (41)

1. Ahearn EP, Juergens T, Cordes T, Becker T, Krahn D. 2011. A review of atypical antipsychotic medications for posttraumatic stress disorder. Int Clin Psychopharmacol 26: 193-200.
2. Alderman CP, McCarthy LC, Condon JT, Marwood AC, Fuller JR. 2009. Topiramate in combat-related posttraumatic stress disorder. Ann Pharmacother 43: 635-641.
3. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4-TR edn. American Psychiatric Association: Washington, DC.
4. th edn. DSM-5. American Psychiatric Association: Washington, DC.
5. Bailey CR, Cordell E, Sobin SM, Neumeister A. 2013. Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment. CNS Drugs 27: 221-232.
6. Berger W, Mendlowicz MV, Margues-Portella C, et al. 2009. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 33: 169-180.
7. Berigan T. 2002. Treatment of posttraumatic stress disorder with tiagabine. Can J Psychiatry 47: 788.
8. Berlant JL. 2001. Topiramate in posttraumatic stress disorder: preliminary clinical observations. J Clin Psychiatry 72: 60-63.
9. Blake DD, Weathers FW, Nagy LM, et al. 1995. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8: 75-90.
10. Clark RD, Canive JM, Calais LA. 1999. Divalproex in posttraumatic stress disorder: an open-label clinical trial. J Trauma Stress 12: 395-401.
11. Cohen J. 1988. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum: Hillsdale, NJ.
12. Connor KM, Sutherland SM, Tupler LA, Malik ML, Davidson JR. 1999. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. Br J Psychiatry 175: 17-22.
13. Davidson JR, Colket JT. 1997. The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. Int Clin Psychopharmacol 12: 41-45.
14. Davidson JR, Book SW, Colket JT, et al. 1997. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med 27: 153-160.
15. Davidson JR, Brady K, Mellman TA, Stein MB, Pollack MH. 2007. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol 27: 85-88.
16. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM. 2001. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 58: 485-492.
17. Davidson JR, Weisler RH, Malik M, Tupler LA. 1998. Fluvoxamine in civilians with posttraumatic stress disorder. J Clin Psychopharmacol 18: 93-95.
18. Davis LL, Davidson JR, Ward LC, Bartolucci A, Bowden CL, Petty F. 2008. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. J Clin Psychopharmacol 28: 84-88.
19. Fesler FA. 1991. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry 52: 361-364.
20. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM. 2007. Randomized, double-blind comparison of sertraline and placebo for post-traumatic stress disorder in a Department of Veterans Affairs setting. J Clin Psychiatry 68: 711-720.
21. Guy W. 1976a. Assessment Manual for Psychopharmacology. National Institute of Mental Health, US Department of Health, Education, and Welfare: Washington, DC.
22. Guy W. 1976b. Clinical global impressions. In ECDEU Assessment Manual for Psychopharmacology. National Institute for Mental Health: RockVille, MD; 218-222. Revised DHEW Publication (ADM).
23. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
24. Hamner MB, Faldowski RA, Robert S, Ulmer HG, Horner MD, Lorberbaum JP. 2009. A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry 21: 89-94.
25. Hertzberg MA, Butterfield MI, Feldman ME, et al. 1999. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 45: 1226-1229.
26. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR. 2000. Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 12: 101-105.
27. Iancu I, Rosen Y, Moshe K. 2002. Antiepileptic drugs in posttraumatic stress disorder. Clin Neuropharmacol 25: 225-229.
28. Ipser JC, Stein DJ. 2012. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol 15: 825-840.
29. Liebowitz MR. 1987. Social phobia. Mod Probl Pharmacopsychiatry 22: 141-173.
30. Lindley SE, Carlson EB, Hill K. 2007. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder. J Clin Psychopharmacol 27: 677-681.
31. Lipov E, Kelzenberg B. 2012. Sympathetic system modulation to treat post-traumatic stress disorder (PTSD): a review of clinical evidence and neurobiology. J Affect Disord 142: 1-5.
32. Lipper S, Davidson JR, Grady TA, et al. 1986. Preliminary study of carbamazepine in post-traumatic stress disorder. Psychosomatics 27: 849-854.
33. Lipper S. 1988. PTSD and carbamazepine. Am J Psychiatry 145: 1322-1323.
34. Mula M, Pini S, Cassano GB. 2007. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J Clin Psychopharmacol 27: 263-272.
35. Nutt DJ. 2000. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 61: 24-29
36. Petty F, Davis LL, Nugent AL, et al. 2002. Valproate therapy for chronic, combat-induced posttraumatic stress disorder. J Clin Psychopharmacol 22: 100-101.
37. Schwartz TL. 2002. The use of tiagabine augmentation for treatment-resistant anxiety disorders: a case series. Psychopharmacol Bull 36: 53-57.
38. Taylor FB. 2003. Tiagabine for posttraumatic stress disorder: a case series of 7 women. J Clin Psychiatry 64: 1421-1425.
39. Tucker P, Trautman RP, Wyatt DB, et al. 2007. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68: 201-206.
40. Yeh MS, Mari JJ, Costa MC, Andreoli SB, Bressan RA, Mello MF. 2011. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neurosci Ther 17: 305-310.
41. Zohar J, Amital D, Miodownik C, et al. 2002. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 22: 190-195.